PHOTODOX
Live / Applied — First extension granted (statement of use) (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 26 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98621217
- Mark type
- Stylized text
- Filed
- 26 Jun 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- Ryan S. Hilbert
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical products for the treatment of viral and infectious diseases for the treatment of cancer; Pharmaceutical preparations for treating cancers and infectious diseases
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals; Medical research in the fields of cancer and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development in the field of cancer therapeutics, oncology, nanoparticles, and targeted therapies
Owner
- POP Biotechnologies, Inc., Buffalo, NY, US
- POP Biotechnologies, Inc., Buffalo, NY, US
Prosecution history
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2025 — SOU EXTENSION 1 GRANTED
- 05 Nov 2025 — SOU EXTENSION 1 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2025 — ASSIGNED TO EXAMINER
- 14 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Jun 2024 — NEW APPLICATION ENTERED